These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Alprenolol ("aptin") in angina pectoris. A double-blind multicentre trial. Hickie JB Med J Aust; 1970 Aug; 2(6):268-72. PubMed ID: 4393977 [No Abstract] [Full Text] [Related]
44. [Clinical effect of oxprenolol in angina pectoris: comparison with a placebo and propranolol by double blind assay]. Murakami M; Murakami E; Takekoshi J; Hayase S; Shintani H Nihon Rinsho; 1973 Apr; 31(4):913-22. PubMed ID: 4580401 [No Abstract] [Full Text] [Related]
45. Practolol--an analysis of clinical trials in angina pectoris. Wiseman RA Acta Cardiol; 1972; Suppl 16():29-42. PubMed ID: 4405743 [No Abstract] [Full Text] [Related]
46. A double blind placebo controlled study of celiprolol in the treatment of angina pectoris. Harston WE; Eff J; Capone P Br J Clin Pract Suppl; 1985 Jun; 40():55-8. PubMed ID: 2864066 [No Abstract] [Full Text] [Related]
47. [Comparative characteristics of the hemodynamic and antianginal actions of obzidan and albetol in patients with stenocardia]. Zaĭtseva VI; Sharaeva ML Vrach Delo; 1988 Dec; (12):15-8. PubMed ID: 2907700 [No Abstract] [Full Text] [Related]
48. [Clinical evaluation of drug efficacy by the double blind method in medicine (author's transl)]. Shimizu N Nihon Naika Gakkai Zasshi; 1976 Jan; 65(1):15-29. PubMed ID: 9459 [No Abstract] [Full Text] [Related]
49. The therapeutic role of propranolol. Fitzgerald JD Int Z Klin Pharmakol Ther Toxikol; 1969 Oct; 2(4):289-91. PubMed ID: 4391518 [No Abstract] [Full Text] [Related]
51. [Clinical trial using the beta receptor blockader Visken]. Szám I; Holló J Med Monatsschr; 1971 Sep; 25(9):425-8. PubMed ID: 4398675 [No Abstract] [Full Text] [Related]
52. [Clinical trial of oxyfedrine and propranolol in angina pectoris]. Chaĭtington DzhR ; Refteri EB Ter Arkh; 1980; 52(5):59-62. PubMed ID: 6996188 [No Abstract] [Full Text] [Related]
53. Angina pectoris: effective therapy once daily. Prager G J Int Med Res; 1979; 7(1):39-44. PubMed ID: 33863 [TBL] [Abstract][Full Text] [Related]
54. [Use of beta-adrenolytic agent in the treatment of angina pectoris]. De Vita C; Cadel A; Carú B; Mazzini C; Parenti GF Minerva Cardioangiol; 1973 Apr; 21(4):304-16. PubMed ID: 4145467 [No Abstract] [Full Text] [Related]
55. A new beta adrenergic blocking agent, propranolol, in the treatment of angina pectoris. Hebb AR; Godwin TF; Gunn RW Can Med Assoc J; 1968 Feb; 98(5):246-51. PubMed ID: 4965821 [No Abstract] [Full Text] [Related]
56. Investigation of verapamil in the treatment of angina pectoris. Sandler G Brux Med; 1970 Sep; 50(9):669-73. PubMed ID: 4928626 [No Abstract] [Full Text] [Related]
57. [Our experience with a new beta-adrenergic blocking agent (Practolol) in angina pectoris]. Rodríguez Alvarez J; Vázquez Guzmán D; Benot Moreno E Rev Esp Cardiol; 1973; 26(5):383-8. PubMed ID: 4588379 [No Abstract] [Full Text] [Related]